Increased Hepatic Iron Content Predicts Poor Survival in Patients With Iron Overload Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation

Sivgin, Serdar; Baldane, Süleyman; DENİZ, KEMAL; ZARARSIZ, GÖKMEN; KAYNAR, LEYLAGÜL; ÇETİN, MUSTAFA; ÜNAL, ALİ; ESER, BÜLENT

doi:10.1016/j.clml.2016.02.005

Increased Hepatic Iron Content Predicts Poor Survival in Patients With Iron Overload Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation

Sivgin S., Baldane S., DENİZ K., ZARARSIZ G., KAYNAR L., ÇETİN M., ...Daha Fazla

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, cilt.16, 2016 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 16
Basım Tarihi: 2016
Doi Numarası: 10.1016/j.clml.2016.02.005
Dergi Adı: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Anahtar Kelimeler: Allogeneic hematopoietic stem cell transplantation, Ferritin, Hepatic iron overload, Survival
Erciyes Üniversitesi Adresli: Evet

Özet

Transfusional iron overload remains a serious problem in alloHSCT setting. Liver is among the most common organs that iron accumulate. The degree of hepatic iron content might be associated with poorer survival in alloHSCT recipients.